Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alchimia is a leading Italian medical device company specializing in the research, development, and production of high-quality materials for ophthalmic surgery and human tissue banking. Founded in 1993 and based in Padua, the company is globally recognized for its expertise in the purification of vitreous substitutes, including silicone oils and perfluorocarbons, which are essential for treating complex retinal conditions. Alchimia also provides a comprehensive range of intraocular dyes for surgical visualization and advanced media for the preservation of transplantable tissues such as corneas and heart valves. The company maintains rigorous quality standards, including ISO 13485 certification, to ensure the safety and biocompatibility of its surgical tools. Alchimia serves a global market, providing critical solutions to surgeons and tissue banks worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AL. CHI. MI.A..